<DOC>
	<DOCNO>NCT00788047</DOCNO>
	<brief_summary>This drug-drug interaction study conduct evaluate potential effect Dimebon pharmacokinetics dextromethorphan , probe substrate cytochrome P450 2D6 ( CYP2D6 ) enzyme , multiple dose administration healthy adult subject .</brief_summary>
	<brief_title>A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Healthy adult subject . Extensive ultrarapid metabolizers CYP2D6 substrate , predict genotype . Existence significant medical condition would impact study result pose unacceptable risk study subject . Pregnant nursing female females childbearing potential unwilling unable use acceptable method contraception . Use prescription nonprescription drug dietary supplement within 7 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>